- Cybin Inc. Presents CYB003 Preclinical Data at Neuroscience 2022
- Cybin Inc. Reports Second Quarter Financial Results and Recent Business Highlights
- Cybin Provides Progress Update on its CYB004-E Phase 1 Trial
- Cybin to Participate in the Jefferies London Healthcare Conference and Upcoming Investor Events
- Cybin Announces Scientific Presentation at the 5th Annual Neuropsychiatric & Psychedelics Drug Development Summit
- Cybin’s EMBARK Program Announces Graduation of Facilitators
- Cybin & The Chopra Foundation Recognize World Mental Health Day
- ALTRD.TV’s Open Minds Documentary Explores the Promising Future of Psychedelic Medicine
- Cybin Provides Update on its Intellectual Property Portfolio
- Cybin Obtains Exclusive License to a Novel Catalog of Psychedelic-Based Compounds
Cybin Inc (R7E1:HAM) closed at 0.4007, 5.70% above its 52-week low of 0.3791, set on Nov 22, 2022.
0.3791Nov 22 20221.30Nov 30 2021
Markit short selling activity
|Market cap||111.13m CAD|
|EPS (TTM)||-0.3337 |
Data delayed at least 15 minutes, as of Nov 25 2022 07:04 GMT.